Andrea Gibson, PhD, and Erin C. Henry, PhD, trace 20 years in retina drug development—and the pathway gap still facing young scientists.
Erin C. Henry, PhD
Advertisement
Erin C. Henry, PhD, is AVP of Ophthalmology, General and Specialty Medicine, Value and Implementation, Global Medical and Scientific Affairs at Merck Research Labs.
Articles by Erin C. Henry, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
RCA releases first State of Retina Care report
2
OT Roundup ep. 1: ADHD's eye link, MOGENRY's BLA, and myopia news
3
FAQ: What retina specialists need to know about the MOGENRY (MCO-010) BLA acceptance
4
Vienna calling: Inside the 26th EURETINA Congress
5